Fungal infections – Page 2

Candida vulturna, the Next Fungal Menace? A Narrative Review

mycolabadmin

Candida vulturna is a newly discovered yeast that causes serious blood infections, particularly in vulnerable patients like premature infants and those with cancer. Though still rare, cases are increasingly appearing in tropical regions with documented hospital outbreaks. While the infection has a better survival rate than related species, it resists several common antifungal drugs, making treatment challenging and requiring careful use of remaining effective medications.

Peritoneal dialysis-related peritonitis caused by Fusarium: a case report and literature review

mycolabadmin

A 61-year-old farmer on peritoneal dialysis developed a rare fungal infection caused by Fusarium after antibiotics failed to treat her peritonitis. Pharmacists helped doctors switch her to the antifungal medication voriconazole and carefully monitored blood levels to ensure the dose was high enough. After adjusting the dose based on blood tests, the patient recovered completely with no symptoms and normal test results within two months.

Epidemiology and outcomes of Candida-associated osteoarticular infections: A multicentre retrospective study from Turkey

mycolabadmin

This study examined 73 patients in Turkey who developed bone and joint infections caused by Candida fungi over ten years. The researchers found that diabetes was very common among patients and made recovery harder, while surgery to clean out infected tissue significantly improved outcomes. Importantly, they discovered resistance to common antifungal medications was higher in certain Candida species compared to others.

Evaluation of Clinical, Microbiological Profiles and Management Patterns with Outcomes of Patients with Fungal Isolates in An Intensive Care Unit of A Tertiary Care Center: A Prospective Observational Study

mycolabadmin

This study examined fungal infections in critically ill patients at a major hospital, tracking 120 patients and their fungal infections. Researchers found that diabetes was the most common risk factor, with most fungal infections occurring in urine samples and commonly caused by Candida tropicalis. The study revealed that many fungal strains were resistant to common antifungal drugs like fluconazole, suggesting that doctors need to carefully choose alternative treatments based on each patient’s specific infection type.

Overexpression of efflux pump and biofilm associated genes in itraconazole resistant Candida albicans isolates causing onychomycosis

mycolabadmin

This research examines why some fungal infections of the nails resist treatment with the antifungal drug itraconazole. Scientists found that resistant fungi produce more proteins that pump the drug out of their cells (efflux pumps) and form protective biofilm structures. Understanding these resistance mechanisms could help develop better combination treatments that work alongside antifungal drugs to overcome resistance.

Disseminated subcutaneous sporotrichosis in an immunocompetent patient: A case report and a systematic literature review

mycolabadmin

A 74-year-old man developed multiple infected lumps on his arm, wrist, and finger months after being injured by a tree branch. Doctors identified the infection as sporotrichosis caused by a fungus called Sporothrix schenckii using advanced genetic testing. He was successfully treated with itraconazole tablets for several months and completely recovered. This case is unusual because sporotrichosis typically affects people with weakened immune systems, but this patient had a normal immune system.

Candida auris: Outbreak, surveillance and epidemiological monitoring in Northern Greece

mycolabadmin

A dangerous fungus called Candida auris caused an outbreak in hospitals in Northern Greece starting in October 2022. This fungus is particularly concerning because it is resistant to many commonly used antifungal drugs, especially fluconazole. Researchers monitored and tracked the outbreak across multiple hospitals, finding that all cases belonged to the same genetic type (Clade I) and were treatable with certain alternative antifungal medications. The study emphasizes the importance of careful laboratory surveillance and coordinated infection control measures to prevent further spread of this serious infection.

Two Cases of Fungal Melanonychia

mycolabadmin

Two patients developed dark pigmentation on their toenails caused by rare combinations of fungal infections. Through laboratory testing and genetic analysis, doctors identified fungi never before known to cause this type of nail discoloration. Both patients were successfully treated with an antifungal medication called efinaconazole, with complete resolution of symptoms within a few months.

A rare case of invasive necrotizing myositis of the thigh caused by Basidiobolus ranarum: a multi-pronged approach to successfully managing a near-fatal polybacterial mycotic infection

mycolabadmin

A 46-year-old man developed a severe, spreading infection of his thigh muscle caused by a rare fungus called Basidiobolus ranarum, likely from an insect bite years earlier that was neglected. The infection became life-threatening when bacteria also invaded the tissue, causing widespread muscle death and bloodstream infection. Doctors treated him with multiple antifungal medications, antibiotics, surgery, and eventually had to amputate his leg to save his life. After six weeks of intensive care combining several medications including potassium iodide and extended oral antifungal therapy, the wound finally healed.

The impact of climate change on the epidemiology of fungal infections: implications for diagnosis, treatment, and public health strategies

mycolabadmin

Climate change is making it easier for dangerous fungi to grow and spread to new areas where people have never encountered them before. As temperatures rise and weather becomes more extreme, fungi are becoming resistant to our medicines, especially antifungal drugs used in both farming and hospitals. People living in poverty, displaced by natural disasters, and those without good healthcare access are most vulnerable to these infections. We need to act quickly by developing new treatments, improving diagnosis, reducing agricultural fungicide use, and strengthening healthcare systems in vulnerable communities.

Research Topic: Fungal infections